This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
ICD-10: D80.4 | Synonyms: Selective IgM deficiency, SIgMD, Immunoglobulin M deficiency
Selective IgM deficiency began to be recognized as an independent clinical entity when Hobbs in 1967 first reported a case of a patient with recurrent infections who had selectively low IgM with normal IgG and IgA. It was regarded as a rare occurrence at the time, but as quantitative immunoglobulin testing became routine, reported cases increased in both adults and children.
Initially, deficiency was defined simply as IgM below the lower limit of normal, but the normal range has been applied differently according to era and age. In 2017, Gupta et al. proposed criteria defining selective IgM deficiency as serum IgM below 2 standard deviations of the age-specific lower limit of normal, with normal IgG and IgA and exclusion of secondary causes.
In Korea, as access to quantitative serum immunoglobulin testing expanded after the 1990s, patients with selective IgM deficiency were reported sporadically. It is often found in cases accompanied by recurrent respiratory infections, autoimmune disease, or malignancy, and cases diagnosed in isolation are only a few in rare disease registration data.
In most cases it is a primary deficiency occurring without a clear causative gene variant. A defect in the IgM production or secretion step of B lymphocytes is presumed to be the most likely mechanism, but the specific molecular defect has not yet been identified in most patients.
Secondary IgM deficiency can be caused by (1) splenectomy or functional asplenia, (2) protein loss due to glomerulonephritis, intestinal lymphangiectasia, etc., (3) lymphoproliferative disorders such as lymphoma and leukemia, (4) use of immunosuppressants (rituximab, corticosteroids), and (5) thymic abnormalities.
In some patients, autoimmune disease accompanies it, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, and idiopathic thrombocytopenic purpura, and in this case it has been raised that the autoimmune response may damage IgM-producing cells.
The genetic basis of selective IgM deficiency is largely unclear. Most cases are sporadic, and familial occurrence is rarely reported. No clear autosomal dominant or recessive inheritance pattern has been established.
The immunoglobulin heavy chain genes are located on chromosome 14 (14q32.33), and the IGHM gene encodes the μ heavy chain of IgM. To date, cases in which germline variants of the IGHM gene itself have been proven to be a major cause of SIgMD are rare.
In some studies, TACI (TNFRSF13B) variants and BAFF-R (TNFRSF13C) variants have been identified in some patients with selective IgM deficiency, but whether they are the direct cause is still unclear. Genome-wide association data are also still insufficiently accumulated.
The exact prevalence of selective IgM deficiency differs between publications because diagnostic criteria are not unified. In healthy control studies, decreased serum IgM (below the lower limit of normal) is reported at about 0.03–0.1% of the adult population. Selective IgM deficiency accompanied by a clinically meaningful immunodeficiency is rarer.
It occurs in both adults and children, and some studies report a slightly higher frequency in males. In children, differentiation from physiologic IgM decrease is important. In some, transient IgM decrease is observed in infancy and early childhood, and this must be distinguished from true deficiency.
In Korea, it is partly counted under the D80 category in the KDCA rare disease registration system, but published data on selective IgM deficiency alone are lacking. It is often found during evaluation of patients with recurrent infections at domestic pediatric immunology institutions.
IgM is the earliest immunoglobulin secreted by B lymphocytes, exists in serum in a pentameric structure, and plays a key role in activation of the classical pathway of the complement system, early defense against bacterial capsular polysaccharide antigens, and clearance of autoantigens as a natural antibody.
In selective IgM deficiency, a defect is presumed in the step of differentiation into IgM-secreting plasma cells or in the mechanism maintaining the survival of IgM-producing B cells. There is no abnormality in class switching itself for IgG and IgA production, but the pool of IgM-secreting B cells is selectively reduced.
IgM is essential for early defense against encapsulated bacteria (pneumococcus, meningococcus, etc.). In IgM deficiency, the T-cell-independent antigen response to these bacteria is reduced, so the risk of invasive bacterial infection increases. The mechanism is similar to the increased risk of pneumococcal sepsis in splenectomized patients.
A substantial number of patients with selective IgM deficiency are found incidentally, without symptoms, on serum immunoglobulin testing. In such cases the clinical significance is unclear, and simple observation alone may be sufficient.
The most common clinical presentation is recurrent respiratory infection. Recurrent otitis media, sinusitis, bronchitis, and pneumonia are especially common in children. The risk of invasive infection by encapsulated bacteria (pneumococcus, Haemophilus influenzae) is high, and bacteremia and meningitis occur rarely.
It has been reported that the frequency of concurrent autoimmune disease (SLE, rheumatoid arthritis, thyroiditis, ITP) in patients with selective IgM deficiency is higher than in the general population. Concurrent allergic diseases such as atopic dermatitis, asthma, and allergic rhinitis are also reported.
There are reports that malignancies such as lymphoma, leukemia, and solid cancer are found concurrently in some adult patients, but the causal relationship is unclear.
In most patients there are no specific findings on physical examination. In patients with recurrent infections, nasal findings from chronic sinusitis and tonsillar and lymph node enlargement or atrophy (an aplasia-like form) are rarely observed.
Serum IgM is decreased to below 2 standard deviations of the age-specific lower limit of normal (generally below 40 mg/dL by adult criteria), while IgG and IgA are within the normal range. Serial measurement of serum IgM levels is important for diagnosis.
On peripheral blood lymphocyte subset analysis, the B-cell count may be normal or mildly decreased. Antigen-specific IgM antibody responses (to pneumococcal antigens, ABO blood group antigens) may be reduced. In some, mild abnormalities in T-cell subset proportions are observed.
When evaluating patients with suspected primary immunodeficiency, quantitative serum immunoglobulin (IgG, IgA, IgM) testing is included in first-line screening. In particular, in patients with a history of recurrent respiratory infections or invasive bacterial infection, it is important to check the IgM level separately.
When decreased serum IgM is confirmed, tests to exclude secondary causes are needed: (1) whether there is protein loss (urine protein, fecal alpha-1 antitrypsin), (2) evaluation of lymph node lesions (imaging), (3) blood cell count and bone marrow examination, and (4) checking whether immunosuppressants are being taken.
In domestic pediatrics and immunology/allergy departments, serum immunoglobulin testing is recognized as a covered item under National Health Insurance when screening for primary immunodeficiency. When persistent decrease is confirmed on 2 or more repeated measurements, the diagnosis can be approached.
The diagnosis of selective IgM deficiency must satisfy the following: (1) serum IgM below 2 standard deviations of the age-specific lower limit of normal, confirmed 2 or more times, (2) normal serum IgG and IgA, (3) exclusion of secondary causes, (4) hypergammaglobulinemia or hypogammaglobulinemia limited to the IgM category
Diseases to be differentiated include (1) common variable immunodeficiency (CVID), (2) X-linked agammaglobulinemia (XLA), (3) Hyper-IgM syndrome (elevated IgM + decreased IgG/IgA), (4) secondary hypogammaglobulinemia, and (5) transient physiologic IgM decrease (neonatal and infant period).
Functional IgM deficiency is checked by assessing the IgM antibody response after vaccination (T-cell-independent antigens: pneumococcal polysaccharide, IgM isohemagglutinins against ABO blood group antigens). B-cell subset analysis (class-switched memory B cells, etc.) may help in understanding the pathogenesis.
Asymptomatic patients with selective IgM deficiency are managed without specific treatment, with regular follow-up serum immunoglobulin tests and surveillance for the occurrence of infection.
For recurrent bacterial infections, the following are recommended: (1) prophylactic antibiotics (amoxicillin, azithromycin, etc.), (2) early antibiotic treatment when infection occurs, and (3) strengthened vaccination (pneumococcal polysaccharide and conjugate vaccines, Haemophilus influenzae type b, meningococcal vaccine).
There is no established standard indication for intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (SCIG) in selective IgM deficiency. Commercial IVIG preparations contain mainly IgG and thus do not directly replace IgM deficiency. However, there are reports that enhancement of opsonization through IgG may help somewhat in preventing infection.
When autoimmune disease is present, standard treatment for that disease is given, but the possibility of a further decrease in IgM level with immunosuppressant use should be considered.
Most patients with selective IgM deficiency have a relatively favorable course, and with regular follow-up and preventive management they can lead normal or near-normal lives.
Appropriate vaccination and prophylactic antibiotics can substantially lower the risk of invasive bacterial infection. However, in splenectomized patients, infants and young children, and patients undergoing immunosuppressive treatment, the risk of life-threatening infections such as pneumococcal sepsis remains.
In some pediatric patients serum IgM normalizes with growth, which is interpreted as the transient deficiency resolving with maturation of the immune system. Adult-onset selective IgM deficiency tends to persist.
Vaccination with pneumococcal conjugate vaccine (PCV13 or PCV15) and polysaccharide vaccine (PPSV23), meningococcal conjugate vaccine, and Haemophilus influenzae type b (Hib) vaccine is strongly recommended. Influenza vaccination is given every year.
When there are recurrent respiratory infections, low-dose prophylactic antibiotics (amoxicillin, azithromycin) are considered. In patients with splenectomy or functional asplenia, prophylactic penicillin is recommended.
Patients and caregivers are educated about warning symptoms of infection and the importance of immediate access to medical care. Regular follow-up serum IgM tests and immune function assessments detect changes in condition early.